Clinical and Microbiologic Characteristics of Cephalosporin-Resistant E. Coli-PITT Protocol
| Status: | Completed |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 6/16/2018 |
| Start Date: | March 2009 |
| End Date: | December 2017 |
The purpose of this study is to review patients with E. coli infections at UPMC from
September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the
community rather than in hospitals or nursing homes and determine their clinical outcomes.
The specific aims of this study are to:
1. Review whether cephalosporin-resistant E. coli infections are hospital-acquired,
healthcare-associated or community-associated.
2. Determine the clinical outcome of the patients according to the antibiotics given.
September 1, 2008 to August 31, 2010 to determine if these infections have arisen in the
community rather than in hospitals or nursing homes and determine their clinical outcomes.
The specific aims of this study are to:
1. Review whether cephalosporin-resistant E. coli infections are hospital-acquired,
healthcare-associated or community-associated.
2. Determine the clinical outcome of the patients according to the antibiotics given.
De-identified data will be obtained by the honest broker for the requested time period. In
addtion, the honest broker will work with the microbiology laboratory to collect the isolates
associated with the de-identified data. All data and samples will be de-identified.
De-identified data will be given to the nurse coordinator to complete the case report forms
and enter the data into the password protected database and the de-identified isolates will
be stored and analyzed on the 8th floor Scaife in Dr. Yohie Doi's laboratory.
addtion, the honest broker will work with the microbiology laboratory to collect the isolates
associated with the de-identified data. All data and samples will be de-identified.
De-identified data will be given to the nurse coordinator to complete the case report forms
and enter the data into the password protected database and the de-identified isolates will
be stored and analyzed on the 8th floor Scaife in Dr. Yohie Doi's laboratory.
Inclusion Criteria:
- patients with E. coli infections at UPMC
Exclusion Criteria:
- not meeting entry criteria
We found this trial at
1
site
Click here to add this to my saved trials
